II
CELG

IFM Investors’s Celgene Corp CELG Stock Holding History

IFM Investors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-75,792
Closed -$7.53M – 626
2019
Q3 		$7.53M Buy
75,792
+25,931
+52% +$2.46M 0.28% 74
2019
Q2 		$4.61M Buy
49,861
+3,768
+8% +$358K 0.26% 81
2019
Q1 		$4.35M Buy
46,093
+4,511
+11% +$395K 0.28% 76
2018
Q4 		$2.67M Buy
41,582
+3,280
+9% +$242K 0.22% 102
2018
Q3 		$3.43M Buy
38,302
+4,193
+12% +$371K 0.26% 82
2018
Q2 		$2.71M Buy
34,109
+9,635
+39% +$800K 0.26% 85
2018
Q1 		$2.18M Buy
24,474
+2,559
+12% +$246K 0.31% 71
2017
Q4 		$2.29M Sell
21,915
-131
-0.6% -$14.8K 0.36% 62
2017
Q3 		$3.21M Buy
22,046
+455
+2% +$62K 0.54% 40
2017
Q2 		$2.8M Buy
21,591
+5,864
+37% +$719K 0.5% 39
2017
Q1 		$1.96M Buy
15,727
+5,847
+59% +$700K 0.49% 40
2016
Q4 		$1.14M Buy
+9,880
New +$1.1M 0.54% 43

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

IFM Investors's CELG Position: Q4 2019 in Review

IFM Investors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 75,792 shares — an estimated $7.53M sold.

IFM Investors first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $7.53M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • IFM Investors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • IFM Investors sold 75,792 Celgene Corp shares in Q4 2019, an estimated $7.53M.
  • IFM Investors first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • IFM Investors's Celgene Corp position peaked at $7.53M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on IFM Investors's 13F filing for Q4 2019, filed 13 Jan 2020.